Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 919	$ 1,338
Accounts receivable, net of allowance of $556 and $587, respectively	115,351	124,069
Inventory	79,233	81,761
Other current assets	8,671	5,989
Total current assets	204,174	213,157
Property, plant and equipment, net	2,372,069	2,301,982
Operating lease right-of-use assets	14,481	14,097
Intangible assets, net	27,293	30,182
Contract costs, net	35,674	37,739
Deferred tax assets	2,445	3,192
Other assets	46,643	47,733
Non-current assets of discontinued operations	7,868	7,868
Total assets	2,710,647	2,655,950
Current liabilities:
Accounts payable, trade	43,976	61,026
Accrued liabilities	83,555	85,381
Deferred revenue	5,661	5,736
Total current liabilities	133,192	152,143
Long-term debt	1,608,956	1,584,869
Operating lease liabilities	12,391	12,271
Deferred tax liabilities	27,310	4,921
Other liabilities	26,434	22,857
Non-current liabilities of discontinued operations	7,868	7,868
Total liabilities	1,816,151	1,784,929
Commitments and contingencies (Note 7)
Equity:
Preferred stock: $0.01 par value per share, 50,000,000 shares authorized, zero issued
Common stock: $0.01 par value per share, 250,000,000 shares authorized, 165,793,798 and 164,984,401 shares issued, respectively	1,658	1,650
Additional paid-in capital	3,478,597	3,470,576
Accumulated deficit	(2,476,793)	(2,499,931)
Treasury stock: 9,493,262 and 9,020,454 common shares, at cost, respectively	(108,966)	(101,274)
Total equity	894,496	871,021
Total liabilities and equity	$ 2,710,647	$ 2,655,950